Please use this identifier to cite or link to this item:
Title: New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes.
Authors: Crasto, W
Jarvis, J
Khunti, K
Davies, MJ
First Published: May-2009
Citation: POSTGRAD MED J, 2009, 85 (1003), pp. 257-267
Abstract: Effective glycaemic control can reduce and potentially prevent the microvascular and macrovascular complications of diabetes. Insulin is the mainstay of treatment for type 1 diabetes and is indicated in patients with type 2 diabetes who do no achieve optimal glycaemic control despite the use of oral hypoglycaemic agents. The advent of the so-called "designer" insulins, the insulin analogues, has offered new opportunities in the clinical management of diabetes. This review examines the efficacy of the different analogue insulins introduced thus far and goes on to explain their pharmacodynamics and pharmacokinetics. The review also examines the different types of insulin regimen currently used in clinical practice and discusses some of the factors that influence the choice of a particular insulin regimen. Further, irrespective of the insulin regimen used, the importance of prompt initiation and ongoing titration of insulin treatment to achieve optimal glycaemic targets is emphasised.
DOI Link: 10.1136/pgmj.2008.067926
eISSN: 1469-0756
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Health Sciences

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.